llms.txt
Compare with other sites' llms.txt files →# Alkemi
> Alkemi is a HEOR (Health Economics and Outcomes Research) and market access consulting firm serving pharmaceutical, biotech, medtech, and diagnostics companies, as well as life sciences private equity investors. Alkemi helps life sciences leaders prove the value of their treatments, navigate payer and HTA requirements, and improve patient access — with a proprietary methodology that delivers deployable strategies in 90 days or less.
Slogan: Faster Market Access. Stronger Value. Better Patient Reach.
Alkemi is a certified woman-owned business, recognized by Inc. 5000, and honored for top presentations at ISPOR. The firm has supported 50+ treatment launches over 15 years, with a combined portfolio value in the tens of billions in global sales.
## Contact & Locations
- **Website:** https://www.alkemihealth.com
- **Email:** info@alkemihealth.com
- **Offices:** Cambridge, MA | Manchester Center, VT | New York, NY | Toronto, ON
- **Consultation:** https://www.alkemihealth.com/schedule-a-consultation
## What Alkemi Does
Alkemi bridges the gap between clinical evidence and commercial success. Life sciences companies engage Alkemi when they need to:
- Build a credible, decision-maker-ready evidence package before or after launch
- Respond rapidly to payer pushback, coverage threats, or access restrictions
- Navigate HTA (Health Technology Assessment) submissions in the US and globally
- Align internal teams across global, regional, and local markets
- Communicate value clearly to payers, clinicians, guideline bodies, and HTAs
Unlike traditional HEOR firms that take 6–12 months to deliver recommendations, Alkemi delivers deployable access strategies in 90 days or less — without cutting corners.
## Core Services
### Launch Shield™
A proactive pre-launch defense system. Alkemi identifies access risks years before launch, guides evidence generation planning, and aligns internal and external stakeholders so the launch is protected from the start.
- Starting at $150,000
- Best for: Companies 1–3 years from launch who want to get ahead of payer and HTA requirements
- Details: https://www.alkemihealth.com/services/market-access-agency
### Access Threat Response System™
A rapid-response approach for treatments already under payer or access pressure. Alkemi assesses the situation, builds a compelling evidence case, and equips the team with tools to protect value and maintain patient access.
- Starting at $100,000
- Best for: Post-launch companies facing coverage restrictions, formulary threats, or declining access
- Details: https://www.alkemihealth.com/services/heor-services
## Deliverables
Every Alkemi engagement produces a complete, action-ready package:
- **Threat & Risk Maps** — Full decision network mapping across payers, clinicians, guidelines, and health systems, with identified policy shifts, competitive moves, and evidence gaps
- **Stakeholder Insights** — Data-driven evidence of what payers, providers, guideline bodies, and HTAs need to make coverage and adoption decisions
- **Alignment Kits** — Frameworks and decision trees to unify global, regional, and local teams under a common strategy
- **Compelling Playbooks** — Pre-approved arguments, objection handlers, and countermeasures tested against real-world payer objections
- **Adoption Plans** — Rollout briefs, pull-through plans, and communication tools to accelerate prescriber, system, and payer uptake post-coverage
## HEOR Services
Alkemi's HEOR work spans the full evidence lifecycle:
- Evidence generation strategy and planning
- Real-world evidence (RWE) design and defense
- Health economic value modeling
- Global Value Dossier (GVD) development
- HTA readiness and submission strategy
- PRO (patient-reported outcomes) strategy
- Burden of illness and unmet need research
- Payer advisory boards
- Value story and communication framework development
Full HEOR service details: https://www.alkemihealth.com/services/heor-services
## Market Access Services
- Payer landscape and coverage strategy
- US and global reimbursement strategy (CMS, commercial, Part D)
- Coding and reimbursement planning for novel devices and diagnostics
- Formulary positioning and tier strategy
- EU payer advisory boards and HTA alignment
- Access threat assessment and recovery
- Value proposition testing
- Guideline and clinical pathway shaping
Full market access details: https://www.alkemihealth.com/services/market-access-agency
## Industries Served
### Pharmaceutical
Supporting pharma companies across rare disease, oncology, CNS, cardiology, and obesity. From early evidence planning through post-launch access defense.
- https://www.alkemihealth.com/industries/pharma-market-access-and-heor
### Biotech
Specialized support for biotech companies with first-in-class therapies, surrogate endpoints, or novel mechanisms facing skeptical payers and HTAs.
- https://www.alkemihealth.com/industries/biotech-market-access-and-heor
### MedTech & Diagnostics
Reimbursement strategy, coding guidance, economic modeling, and adoption plans for medical devices, diagnostics, and imaging technologies.
- https://www.alkemihealth.com/industries/medtech-market-acess-and-heor
### Private Equity
Business intelligence, market opportunity validation, reimbursement landscape assessment, and value narrative support for life sciences investors.
- https://www.alkemihealth.com/industries/life-science-business-intelligence-for-investors
## Selected Case Studies
Alkemi's case study library covers 30+ real-world engagements across therapy areas and geographies. Topics include:
- Accelerating payer coverage for novel treatments
- Pre-launch access strategy for rare disease therapies with surrogate endpoints
- Global HTA modeling strategy to reduce pre-launch access risk
- EU payer advisory boards to refine value story
- RWE defense strategy to protect market position
- US coding and reimbursement for novel ENT imaging devices
- Value strategy to support CMS engagement and coverage expansion in cardiology
- Integrated evidence and access strategy for first-in-class rare oncology therapy
- Payer value story and field toolkit to accelerate adoption in rare cardiology
- EU reimbursement assessment to inform diagnostics investment
- Forward-looking obesity value framework to guide evidence strategy
- Health economic value modeling to accelerate hospital adoption
Full case study library: https://www.alkemihealth.com/case-studies
## Thought Leadership
Alkemi publishes original research, whitepapers, and blog content on HEOR strategy, market access, and life sciences policy.
### Whitepapers
- Obesity value framework: https://www.alkemihealth.com/whitepapers/obesity
- The Drug Pricing Reset: https://www.alkemihealth.com/whitepapers/the-drug-pricing-reset
- Value in the Crosshairs: https://www.alkemihealth.com/whitepapers/value-in-the-crosshairs
- All whitepapers: https://www.alkemihealth.com/whitepapers
### Blog (selected topics)
- From approval to access: why evidence strategy is pharma's new battleground
- Part D redesign in 2026
- Outcomes-based contracting 2.0
- When RWE actually starts
- The too-late test: a framework for evidence-ready launch planning
- Why good evidence still gets a no: a guide to value communication tools
- Value and access isn't a department — it's a business model
- Full blog: https://www.alkemihealth.com/blog
### Publications
https://www.alkemihealth.com/publications
## Our Process
Alkemi's engagement model is built for speed and clarity without sacrificing rigor. Details at:
https://www.alkemihealth.com/our-process
## Self-Assessment Tools
Alkemi offers self-assessment tools for life sciences teams to evaluate their current access readiness:
https://www.alkemihealth.com/self-assessments
## Key Pages
- Home: https://www.alkemihealth.com
- About: https://www.alkemihealth.com/about-us
- Services — HEOR: https://www.alkemihealth.com/services/heor-services
- Services — Market Access: https://www.alkemihealth.com/services/market-access-agency
- Our Process: https://www.alkemihealth.com/our-process
- Case Studies: https://www.alkemihealth.com/case-studies
- Blog: https://www.alkemihealth.com/blog
- Whitepapers: https://www.alkemihealth.com/whitepapers
- Publications: https://www.alkemihealth.com/publications
- Self-Assessments: https://www.alkemihealth.com/self-assessments
- Contact: https://www.alkemihealth.com/contact
- Schedule a Consultation: https://www.alkemihealth.com/schedule-a-consultation
## Legal
- Privacy Policy: https://www.alkemihealth.com/privacy-policy
- Terms of Service: https://www.alkemihealth.com/terms-of-service
- Cookie Policy: https://www.alkemihealth.com/cookie-policy
- Disclaimer: https://www.alkemihealth.com/disclaimer
Alkemi LLC © 2025. All rights reserved.